Medicine’s use in obstetrics by gestational risk category: An integrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v14i2.48353

Keywords:

Obstetrics; Security; Teratogens.

Abstract

This study aimed to identify if the medications used in obstetrics meet the Food and Drug Administration - FDA risk categories. This is an integrative review, in which searches were carried out in the PubMed, SciELO, and Cochrane databases using descriptors. To select publications, the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses - PRISMA were followed. 61 articles were identified, 6 of which were duplicates and were excluded, as well as another 34, discarded after reading the titles and abstracts and 15 after reading in full. Therefore, 6 articles were selected for the study by the proposed objective. In this integrative review, it was observed that pregnant women used different pharmacological classes, so the prescription of potentially harmful medications to pregnant women was not uncommon. Even so, the importance of risk-benefit assessment for the pregnant woman and the fetus, considering that it is possible to face situations in which administering vital treatments for certain chronic conditions may present significant benefits in detriment of the risk.

References

Alemu, B. K., & Wolle, N. N. (2019). Prescription drug use and potential teratogenicity risk among pregnant women attending the maternal and child health clinic of Kemisse General Hospital, Northeast Ethiopia. BMC Research Notes, 12(592). https://doi.org/10.1186/s13104-019-4641-1

Anacleto, T. A. (2019). Uso seguro de medicamentos na gestação (10ª ed.). Belo Horizonte, MG: ISMP Brasil.

Andrade, S. E., Gurwitz, J. H., Davis, R. L., et al. (2004). Prescription drug use in pregnancy. American Journal of Obstetrics and Gynecology, 191(2), 398-407. https://doi.org/10.1016/j.ajog.2004.04.025

Ânima Educação. (2014). Manual revisão bibliográfica sistemática integrativa: a pesquisa baseada em evidências. Grupo Anima. https://biblioteca.cofen.gov.br/wp-content/uploads/2019/06/manual_revisao_bibliografica-sistematica-integrativa.pdf.

Ayad, M., & Costantine, M. M. (2015). Epidemiology of medication use in pregnancy. Seminars in Perinatology, 39(7), 508-511. https://doi.org/10.1053/j.semperi.2015.08.002

Azevedo G. C. A., Silva L. M. da S. e, & Silva F. S. R. F. C. da. (2025). Farmácia clínica na internação obstétrica: uso de medicamentos por categoria de risco teratogênico em um hospital universitário. Revista Eletrônica Acervo Saúde, 25, e18412. https://doi.org/10.25248/reas.e18412.2025

Belete, T. M., Sisay, G., Mengesha, E., Dandena, A., Simegn, W., Mengesha, A. K., et al. (2022). Prescription pattern and associated factors among pregnant women attending antenatal clinics in University of Gondar, North West Ethiopia. Heliyon, 8(12), e09781. https://doi.org/10.1016/j.heliyon.2022.e12156

Blotière, P. O., Damase-Michel, C., Weill, A., & Maura, G. (2021). Dispensing of potentially harmful prescription drugs in 1.8 million pregnant women in France: A nationwide study based on two risk classification systems. Drug Safety, 44, 1323–1339. https://doi.org/10.1007/s40264-021-01117-4

Briggs, G. G., Freeman, R. K., & Yaffe, S. J. (2017). Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk (11th ed.). 11th ed. Wolters Kluwer, 2017.

Carmo, T. A., & Nitrini, S. M. O. (2004). Prescrições de medicamentos para gestantes: Um estudo farmacoepidemiológico. Cadernos de Saúde Pública, 20(4), 1004-1013.

Constantine, M. M. (2014). Physiologic and pharmacokinetic changes in pregnancy. Frontiers in Pharmacology, 5, 65. https://doi.org/10.3389/fphar.2014.00065

Costa, D. B., Coelho, H. L. L., & Santos, D. B. (2017). Utilização de medicamentos antes e durante a gestação: Prevalência e fatores associados. Cadernos de Saúde Pública, 33(2), e00116415. https://doi.org/10.1590/0102-311X00126215

Crossetti, M. G. M. (2012). Revisión integradora de la investigación en enfermería el rigor científico que se le exige. Revista Gaúcha de Enfermagem, 33(2), 8-9.

FDA. (2014). Pregnancy and Lactation Labeling (Drugs) Final Rule. Retrieved. Disponível em: https://www.fda.gov/drugs/labeling-information-drug-products/pregnancy-and-lactation-labeling-drugs-final-rule

Gandolfi, F. R. R., Gomes, M. F. P., Reticena, K. O., Santos, M. S., & Damini, N. M. A. V. (2019). Mudanças na vida e no corpo da mulher durante a gravidez. Brazilian Journal Of Surgery And Clinical Research, 27(1), 126-131.

Gomes, J. C. O., & Domingueti, C. P. (2021). Fatores de risco da gravidez tardia. Brazilian Journal of Health and Pharmacy, 3(4), 1-9.

Hodosan, V., Daina, C. M., Zaha, D. C., Cotrau, P., Vladu, A., Pantis, C., et al. (2022). Pattern of antibiotic use in the perinatal period in a public university hospital in Romania. Medicina, 58(772). https://doi.org/10.3390/medicina58060772

Leke, A. Z., Dolk, H., Loane, M., Casson, K., Maboh, N. M., Maeya, S. E., et al. (2018). First-trimester medication use in pregnancy in Cameroon: A multi-hospital survey. BMC Pregnancy and Childbirth, 18(450). https://doi.org/10.1186/s12884-018-2081-x

Mattos, P. C. (2015). Tipos de revisão de literatura. Universidade Estadual Paulista (Unesp). https://www.fca.unesp.br/Home/Biblioteca/tipos-de-evisao-de-literatura.pdf.

Melo, S. C. C. S., Pelloso, S. M., Carvalho, M. D. B., & Oliveira, N. L. B. (2009). Uso de medicamentos por gestantes usuárias do Sistema Único de Saúde. Acta Paulista de Enfermagem, 22(1), 66–70. https://doi.org/10.1590/S0103-21002009000100011

Ministério da Saúde. (2019). Nota técnica para organização da rede de atenção à saúde com foco na Atenção Primária à saúde e na Atenção Ambulatorial Especializada: Saúde da mulher na gestação, parto e puerpério (1ª ed.). São Paulo: Ministério da Saúde. 60 p.

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), e1000097. https://doi.org/10.1371/journal.pmed.1000097

Moro, A., & Invernizzi, N. (2017). A tragédia da talidomida: A luta pelos direitos das vítimas e por melhor regulação de medicamentos. História, Ciências, Saúde – Manguinhos, 24(3), 603-622. https://doi.org/10.1590/S0104-59702017000300004

Pereira, A. S., Shitsuka, D.M., Parreira, F.J., & Shitsuka, R. (2018). Metodologia da pesquisa científica [e-book]. Editora UAB/NTE/UFSM. https://www.ufsm.br/app/uploads/sites/358/2019/02/Metodologia-da-Pesquisa-Cientifica_final.pdf.

Synder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of business research, 104, 333-339 https://doi.org/10.1016/j.jbusres.2019.07.039

Tamirci, M., Akici, A., Aydin, V., Sakarya, S., & Goren, M. Z. (2021). Evaluation of the knowledge, attitude, and behaviors of physicians and pharmacists regarding the use of medicines in pregnancy. Journal of Research in Pharmacy, 25(2), 218-229. https://dx.doi.org/10.29228/jrp.12

Published

28/02/2025

How to Cite

AZEVEDO, G. C. A.; SILVA, F. S. R. F. C. da; FURTADO, D. F.; REIS, J. S. L. Medicine’s use in obstetrics by gestational risk category: An integrative review . Research, Society and Development, [S. l.], v. 14, n. 2, p. e13814248353, 2025. DOI: 10.33448/rsd-v14i2.48353. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/48353. Acesso em: 2 apr. 2025.

Issue

Section

Review Article